Loading company…
Netanya-based biotech developing TBX products that deliver biotherapeutics through the gut microbiome for metabolic disease and cancer.
Founded in 2018 in Netanya, Israel by Adi Elkeles, Trobix Innovation Ltd. develops TBX products for in vivo gut production of biotherapeutics. Its engineered phage approach delivers DNA cargo to target bacteria using CRISPR and synthetic biology, aiming at metabolic inflammatory conditions and cancer. Its customers include hospitals, clinics and research institutions in North America and Europe. In March 2023 the company raised USD 3.00 mn in Series A funding from Chartered Group, part of a USD 6.00 mn round, and has completed 4 deals in total.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in